Abstract
Maarten Taal discusses the potential benefits, risks, and evidence base relating to screening policies for chronic kidney disease.
MeSH terms
-
Disease Progression*
-
Humans
-
Renal Insufficiency, Chronic / epidemiology*
-
Risk Assessment / methods*
Grants and funding
No specific funding was received for writing this article.